HOME > ARCHIVE
ARCHIVE
- Korosho Announces Proposals for Structural Healthcare Reform
October 31, 2005
- Opposition from All Stakeholders
October 31, 2005
- Diet Member Starts Discussions on Korosho's Proposals
October 31, 2005
- MOF, Korosho, JMA Debate Korosho's Healthcare Reform Proposals
October 31, 2005
- Opinions Clash over New Prescription Format Proposed by Korosho
October 31, 2005
- PMDA to Give Conditional Approval to More New Drugs: Dr Doi
October 31, 2005
- REGULATORY NEWS IN BRIEF
October 31, 2005
- A Cluster of Diseases - Metabolic Syndrome:Reflecting an Aging Society -2-
October 31, 2005
- Japanese Society of National Medical Service Meets in Hiroshima
October 31, 2005
- MEDICAL DEVICE NEWS IN BRIEF
October 31, 2005
- Chugai Reports Efficacy of Tocilizumab in PIII Study in Japan
October 31, 2005
- York Pharma Lands in Japan
October 31, 2005
- R&D NEWS IN BRIEF
October 31, 2005
- Pfizer Seeks Preliminary Injunction for Return of Data on Amlodipine: DSP
October 31, 2005
- Nihon Medi-Physics Start FDGscan Business in Earnest
October 31, 2005
- SURVEY 3 articles
October 31, 2005
- JPLA LECTURE
October 31, 2005
- Will Gov't Be Able to Stockpile Tamiflu through Public Tender?
October 31, 2005
- PHAEMA DELEGATES
October 31, 2005
- 7th IPLS in Madrid Highlights Importance of Partnering
October 24, 2005
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
